262 related articles for article (PubMed ID: 20148830)
1. Many faces of graft-versus-host disease.
Peñas PF; Zaman S
Australas J Dermatol; 2010 Feb; 51(1):1-10; quiz 11. PubMed ID: 20148830
[TBL] [Abstract][Full Text] [Related]
2. The changing face of graft-versus-host disease.
Schaffer JV
Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
[TBL] [Abstract][Full Text] [Related]
3. Oral graft-versus-host disease.
Schubert MM; Correa ME
Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
[TBL] [Abstract][Full Text] [Related]
4. Lichen sclerosus et atrophicus-like graft-versus-host disease post stem cell transplant.
Weinberg JL; Rosenbach M; Kim EJ; Kovarik CL
Dermatol Online J; 2009 Sep; 15(9):4. PubMed ID: 19930991
[TBL] [Abstract][Full Text] [Related]
5. Clinical update on graft-versus-host disease in children.
Goddard DS; Horn BN; McCalmont TH; Cordoro KM
Semin Cutan Med Surg; 2010 Jun; 29(2):92-105. PubMed ID: 20579598
[TBL] [Abstract][Full Text] [Related]
6. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
Grauer O; Wolff D; Bertz H; Greinix H; Kühl JS; Lawitschka A; Lee SJ; Pavletic SZ; Holler E; Kleiter I
Brain; 2010 Oct; 133(10):2852-65. PubMed ID: 20846944
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for acute graft-versus-host disease.
Khaled Y; Reddy P; Krijanovski O
Expert Opin Emerg Drugs; 2009 Jun; 14(2):219-32. PubMed ID: 19519285
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].
Martínez C
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():69-71. PubMed ID: 21381292
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
Schmook T; Kraft J; Benninghoff B; Nindl I; Roewert J; Ulrich C; Stockfleth E
Bone Marrow Transplant; 2005 Jul; 36(1):87-8. PubMed ID: 15895116
[No Abstract] [Full Text] [Related]
10. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
Terrier B; Delmas Y; Hummel A; Presne C; Glowacki F; Knebelmann B; Combe C; Lesavre P; Maillard N; Noël LH; Patey-Mariaud de Serre N; Nusbaum S; Radford I; Buzyn A; Fakhouri F
Nephrol Dial Transplant; 2007 May; 22(5):1369-76. PubMed ID: 17255123
[TBL] [Abstract][Full Text] [Related]
11. Chronic graft versus host disease of oral mucosa: review of available therapies.
Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
[TBL] [Abstract][Full Text] [Related]
12. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous graft-versus-host disease: a guide for the dermatologist.
Häusermann P; Walter RB; Halter J; Biedermann BC; Tichelli A; Itin P; Gratwohl A
Dermatology; 2008; 216(4):287-304. PubMed ID: 18230976
[TBL] [Abstract][Full Text] [Related]
14. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening graft-vs-host disease.
Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of chronic graft-versus-host disease.
Hymes SR; Turner ML; Champlin RE; Couriel DR
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1101-13. PubMed ID: 17085303
[TBL] [Abstract][Full Text] [Related]
18. The management and outcome of chronic graft-versus-host disease.
Fraser CJ; Scott Baker K
Br J Haematol; 2007 Jul; 138(2):131-45. PubMed ID: 17593020
[TBL] [Abstract][Full Text] [Related]
19. Update on the management of acute graft-versus-host disease.
Bolaños-Meade J
Curr Opin Oncol; 2006 Mar; 18(2):120-5. PubMed ID: 16462179
[TBL] [Abstract][Full Text] [Related]
20. Update on ocular graft versus host disease.
Kim SK
Curr Opin Ophthalmol; 2006 Aug; 17(4):344-8. PubMed ID: 16900025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
